Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teduglutide for Gut Integrity and Inflammation in HIV
NCT02431325Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2015
- Primary completion
- Jan 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of teduglutide in human immunodeficiency virus infection (HIV), sponsored by Massachusetts General Hospital. Started Dec 2015; status: completed.
02
Drugs
teduglutide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02431325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431325.